Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rayner

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Plos One|October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignMicaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 5, 2013
Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South AfricansRetsilisitsoe R Moholisa, Brian R Rayner, E Patricia Owen, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersBarbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, et al.
Basic & Clinical Pharmacology & Toxicology|May 20, 2011
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in JapanNaohisa Uchimura, Hiroo Kuwahara, Yuji Kumagai, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2008
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteersS S Jhee, M Yen, L Ereshefsky, et al.
Advances in Therapy|October 12, 2012
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated reviewStephen Toovey, Eric P Prinssen, Craig R Rayner, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2024
Advancing pharmacometrics in Africa-Transition from capacity development toward job creationGoonaseelan Colin Pillai, Samer Mouksassi, Innocent G Asiimwe, et al.
Cancer Treatment Reviews|June 1, 1989
Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanomaM Sznol, J P Dutcher, M B Atkins, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Plos One|October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignMicaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 5, 2013
Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South AfricansRetsilisitsoe R Moholisa, Brian R Rayner, E Patricia Owen, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersBarbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, et al.
Basic & Clinical Pharmacology & Toxicology|May 20, 2011
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in JapanNaohisa Uchimura, Hiroo Kuwahara, Yuji Kumagai, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2008
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteersS S Jhee, M Yen, L Ereshefsky, et al.
Advances in Therapy|October 12, 2012
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated reviewStephen Toovey, Eric P Prinssen, Craig R Rayner, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2024
Advancing pharmacometrics in Africa-Transition from capacity development toward job creationGoonaseelan Colin Pillai, Samer Mouksassi, Innocent G Asiimwe, et al.
Cancer Treatment Reviews|June 1, 1989
Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanomaM Sznol, J P Dutcher, M B Atkins, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Pageof 15